Plain-English translation of NCT07484009 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a device called ReDS — which measures fluid buildup in your lungs — can help doctors decide when you're ready to leave the hospital and prevent serious heart problems after discharge. The ReDS device will be used daily during your hospital stay to guide your treatment plan. Researchers want to see if this approach works better than the standard way doctors currently decide when heart failure patients are ready to go home.
Currently, doctors use their clinical judgment to decide when heart failure patients have improved enough to leave the hospital, but there's no standard measurement to guide these decisions. This trial aims to see whether using the ReDS device to track fluid levels could help prevent complications after discharge and improve patient outcomes.
You likely qualify if…
You likely don't qualify if…
Each day during your hospital stay, a device called ReDS will measure fluid in your lungs to help your doctor adjust your medications and plan your discharge. Your doctor will follow a specific protocol to determine when you're ready to go home based on your ReDS readings and overall clinical improvement. After you leave the hospital, you'll have two follow-up visits — one at 2 weeks and another at 30 days — to check how you're doing and make sure you're recovering well.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Spain